An edition of Essential CNS drug development (2012)

Essential CNS drug development

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Essential CNS drug development
Amir Kalali
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

Buy this book

Last edited by MARC Bot
September 25, 2020 | History
An edition of Essential CNS drug development (2012)

Essential CNS drug development

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

"Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians"--Provided by publisher.

Publish Date
Language
English

Buy this book

Edition Availability
Cover of: Essential CNS Drug Development
Essential CNS Drug Development
2012, Cambridge University Press
in English
Cover of: Essential CNS Drug Development
Essential CNS Drug Development
2012, Cambridge University Press
in English
Cover of: Essential CNS drug development
Essential CNS drug development
2012, Cambridge University Press
in English
Cover of: Essential CNS Drug Development
Essential CNS Drug Development
2012, University of Cambridge ESOL Examinations
in English

Add another edition?

Book Details


Published in

Cambridge

Table of Contents

Machine generated contents note: History of CNS drug development / Sheldon H. Preskorn
Regulatory issues / Gwen L. Zornberg
Pre-clinical development / Alan J. Cross and Frank D. Yocca
Phase I trials: from traditional to newer approaches / Matthew Macaluso, Michael Krams and Sheldon H. Preskorn
Phase II development and the path to personalized medicine in CNS disease / Douglas E. Feltner and Kenneth R. Evans
CNS drug development - Phase III / Judith Dunn, Penny Randall and Amir Kalali / Statistics issues relevant to CNS drug development / Craig H. Mallinckrodt, William R. Prucka and Geert Molenberghs
Clinical trials management at company level / Nuala Murphy
Clinical trials management at the site level / Joseph Kwentus
Medical writing for CNS indications / Ginette Nachman
Dissemination of clinical trial information: multiple audiences, multiple formats / Leslie Citrome
The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date / Philip D. Harvey and Richard S. E. Keefe
Leveraging disruptive technologies to drive innovation in CNS clinical drug development / Penny Randall, Judith Dunn and Amir Kalali.

Edition Notes

Includes bibliographical references and index.

Classifications

Dewey Decimal Class
615.1/9
Library of Congress
RM301.25 .E82 2012

The Physical Object

Pagination
p. ;

ID Numbers

Open Library
OL25102226M
ISBN 13
9780521766067
LCCN
2011046215

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
September 25, 2020 Edited by MARC Bot import existing book
August 21, 2020 Edited by ImportBot import existing book
November 16, 2011 Created by LC Bot import new book